178 related articles for article (PubMed ID: 37234150)
1. Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma.
Zhang Y; Han S; Xiao X; Zheng L; Chen Y; Zhang Z; Gao X; Zhou S; Yu K; Huang L; Fu J; Hong Y; Jiang J; Qian W; Yang H; Shen J
Front Immunol; 2023; 14():1146861. PubMed ID: 37234150
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.
Lin Z; Mao D; Jin C; Wang J; Lai Y; Zhang Y; Zhou M; Ge Q; Zhang P; Sun Y; Xu K; Wang Y; Zhu H; Lai B; Wu H; Mu Q; Ouyang G; Sheng L
Front Immunol; 2023; 14():1105293. PubMed ID: 36891300
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma.
Shin HJ; Kim DY; Chung J; Shin KH; Lee H
Acta Haematol; 2021; 144(4):427-437. PubMed ID: 33271543
[TBL] [Abstract][Full Text] [Related]
4. Immunogenomic-Based Analysis of Hierarchical Clustering of Diffuse Large Cell Lymphoma.
Wang L; Yuan W; Li L; Shen Z; Geng Q; Zheng Y; Zhao J
J Immunol Res; 2022; 2022():9544827. PubMed ID: 35983077
[TBL] [Abstract][Full Text] [Related]
5. Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma.
Głowala-Kosińska M; Chwieduk A; Nieckula J; Saduś-Wojciechowska M; Grosicki S; Rusin A; Nowara E; Giebel S
Eur J Haematol; 2013 Aug; 91(2):122-8. PubMed ID: 23679234
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in peripheral blood lymphocyte subset counts and functions in patients with diffuse large B cell lymphoma during chemotherapy.
Hou H; Luo Y; Tang G; Zhang B; Ouyang R; Wang T; Huang M; Wu S; Li D; Wang F
Cancer Cell Int; 2021 May; 21(1):282. PubMed ID: 34044841
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
Huang H; Fan L; Fu D; Lin Q; Shen J
Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
[TBL] [Abstract][Full Text] [Related]
8. Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma.
Higashi M; Tokuhira M; Fujino S; Yamashita T; Abe K; Arai E; Kizaki M; Tamaru J
Leuk Lymphoma; 2016; 57(1):161-6. PubMed ID: 25860238
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study.
Yamamoto W; Nakamura N; Tomita N; Takeuchi K; Ishii Y; Takahashi H; Watanabe R; Takasaki H; Motomura S; Kobayashi S; Yokose T; Ishigatsubo Y; Sakai R
Leuk Lymphoma; 2014 Dec; 55(12):2721-7. PubMed ID: 24528218
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic Value of CD14
Wu CX; Qiang M; Hao JQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):816-819. PubMed ID: 31204937
[TBL] [Abstract][Full Text] [Related]
11. Value of
Jiang C; Teng Y; Chen J; Wang Z; Zhou Z; Ding C; Xu J
Ann Nucl Med; 2020 Dec; 34(12):911-919. PubMed ID: 33057996
[TBL] [Abstract][Full Text] [Related]
12. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
[TBL] [Abstract][Full Text] [Related]
13. Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape.
Su X; Sun T; Li M; Xia Y; Li M; Wang D; Lu F; Ye J; Ji C
J Transl Med; 2022 Aug; 20(1):378. PubMed ID: 35986288
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota and Immune Modulatory Properties of Human Breast Milk
Li S; Li N; Wang C; Zhao Y; Cao J; Li X; Zhang Z; Li Y; Yang X; Wang X; Che C; Zhao Y; Wang L; Zhao L; Shen J
Front Nutr; 2022; 9():798403. PubMed ID: 35273986
[TBL] [Abstract][Full Text] [Related]
16. The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma.
Yang Y; Wang L; Ma Y; Han T; Huang M
Am J Med Sci; 2017 May; 353(5):459-465. PubMed ID: 28502332
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era.
Chen H; Zhong Q; Zhou Y; Qin Y; Yang J; Liu P; He X; Zhou S; Zhang C; Gui L; Yang S; Zhou L; Shi Y
BMC Cancer; 2022 May; 22(1):583. PubMed ID: 35624433
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of peripheral monocytic myeloid-derived suppressor cells and monocytes in patients newly diagnosed with diffuse large b-cell lymphoma.
Wu C; Wu X; Zhang X; Chai Y; Guo Q; Li L; Yue L; Bai J; Wang Z; Zhang L
Int J Clin Exp Med; 2015; 8(9):15173-81. PubMed ID: 26629001
[TBL] [Abstract][Full Text] [Related]
19. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between Peripheral Blood Intermediate Monocytes Increased and the Disease Progression of Patients with Diffuse Large BCell Lymphoma].
Hu QQ; Wang HP; Gu KS; Zhai ZM; Li YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1116-1122. PubMed ID: 35981370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
